Pages that link to "Q35007597"

The following pages link to Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices (Q35007597):

Displaying 27 items.

• Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma Cells (Q28553620) (← links)
• Ecstasy: are animal data consistent between species and can they translate to humans? (Q31033315) (← links)
• Therapeutic and adverse actions of serotonin transporter substrates (Q34142899) (← links)
• A comprehensive review of MDMA and GHB: two common club drugs (Q34476901) (← links)
• Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue (Q34607458) (← links)
• Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters (Q35107898) (← links)
• Electroencephalographic and convulsive effects of binge doses of (+)-methamphetamine, 5-methoxydiisopropyltryptamine, and (±)-3,4-methylenedioxymethamphetamine in rats. (Q35618891) (← links)
• MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning (Q37452207) (← links)
• Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA). (Q38652284) (← links)
• MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. (Q40362823) (← links)
• Acute and long-term effects of ecstasy (Q40518413) (← links)
• Activation of 5-HT3 receptors leads to altered responses 6 months after MDMA treatment (Q43201597) (← links)
• 3,4-methylenedioxymethamphetamine induces gene expression changes in rats related to serotonergic and dopaminergic systems, but not to neurotoxicity (Q43543985) (← links)
• Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA. (Q43842107) (← links)
• The effects of dentate granule cell destruction on behavioral activity and Fos protein expression induced by systemic MDMA in rats (Q44454418) (← links)
• Stimulant doping agents used in Brazil: prevalence, detectability, analytical implications, and challenges (Q45405141) (← links)
• Initial deficit and recovery of function after MDMA preexposure in rats (Q46857178) (← links)
• Β-N-Methylamino-L-Alanine (BMAA) Toxicity Is Gender and Exposure-Age Dependent in Rats (Q47244005) (← links)
• A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases (Q47891276) (← links)
• MDMA induces EPSP-Spike potentiation in rat ventral hippocampus in vitro via serotonin and noradrenaline release and coactivation of 5-HT4 and beta1 receptors (Q48095503) (← links)
• The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain (Q48149811) (← links)
• Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices (Q48328073) (← links)
• Cardiovascular and sympathetic responses and reflex changes elicited by MDMA. (Q51381678) (← links)
• The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers (Q51971591) (← links)
• Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine (Q57176236) (← links)
• Identification of an acetal derivative of the piperonyl methyl ketone in tablets seized for suspected drug trafficking (Q57976339) (← links)
• Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms (Q73371204) (← links)